Licensed Bacille Calmette-Guérin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation. (2020)

First Author: Angelidou A
Attributed to:  Childhood tuberculosis: Integrating tools for improved diagnosis and vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2019.11.060

PubMed Identifier: 32005538

Publication URI: http://europepmc.org/abstract/MED/32005538

Type: Journal Article/Review

Volume: 38

Parent Publication: Vaccine

Issue: 9

ISSN: 0264-410X